Browsing: regulatory

Pila Pharma has received regulatory approval from the European Medicines Agency to conduct PP-CT04, a randomised, double-blind, placebo-controlled trial evaluating XEN-D0501 in people living with obesity over 12 weeks. The trial will explore doses up to four times higher than those studied previously and over significantly longer duration. BioStock contacted CEO Gustav Hanghøj Gram to…

Maintaining a balanced immunity between pathogen defense and tolerance to environmental antigens in neonates is essential for survival and the establishment of life-long immune homeostasis. Instructed by environmental signals, type 1 conventional dendritic cells (cDC1) contribute to both processes but how the balance may be achieved is unclear. Here, we uncover an interferon (IFN)γ-driven regulatory…